Kairos Pharma Ltd. Recorded Big Gain

Kairos Pharma Ltd. (KAPA:NYSEMKT) soared at $2.13, a gain of 119.6%. On Mon, Jan 13, 2025, KAPA:NYSEMKT touched a New 2-Week High of $2.13. The stock got featured on our News Catalysts scanner on Tue, Jan 07, 2025 at 09:51 AM in the 'MISCELLANEOUS' category. From Tue, Dec 31, 2024, the stock recorded 57.14% Up Days and 37.50% Green Days
The stock spiked on Mon, Jan 13, 2025 at $3.25 with a volume of 113M+.
About Kairos Pharma Ltd. (KAPA:NYSEMKT)
Kairos Pharma is a clinical-stage biopharmaceutical company advancing therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance.
Top 10 Gainers:
- Phio Pharmaceuticals Corp. (PHIO:NASDAQ), 290.53%
- Smart for Life Inc. (SMFL:NASDAQ), 260%
- Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ), 135.26%
- Kairos Pharma Ltd. (KAPA:NYSEMKT), 119.59%
- Azitra Inc (AZTR:NYSEMKT), 59.72%
- Agape ATP Corporation (ATPC:NASDAQ), 56.35%
- Avinger, Inc. (AVGR:NASDAQ), 42.62%
- Neuronetics, Inc. (STIM:NASDAQ), 36.84%
- Sage Therapeutics, Inc. (SAGE:NASDAQ), 35.14%
- Intra-Cellular Therapies, Inc. (ITCI:NASDAQ), 34.07%